Ginkgolic acids inhibit SARS-CoV-2 and its variants by blocking the spike protein/ACE2 interplay
Yusen Xiang, Guanglei Zhai, Yaozong Li, Mengge Wang, Xixiang Chen, Ruyu Wang, Hang Xie, Weidong Zhang, Guang‐Bo Ge, Qian Zhang, Yechun Xu, Amedeo Caflisch, Jianrong Xu, Hongzhuan Chen, Lili Chen
Topics & Concepts
CoronavirusDocking (animal)Small moleculeMutagenesisSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ChemistryPlasma protein bindingHEK 293 cellsAngiotensin-converting enzyme 2Coronavirus disease 2019 (COVID-19)Binding siteSurface plasmon resonanceProtein–protein interactionComputational biologyBiologyMutationReceptorBiochemistryGeneMedicineDiseaseInfectious disease (medical specialty)NanotechnologyMaterials scienceNursingPathologyNanoparticleComputational Drug Discovery MethodsPharmacological Effects of Natural CompoundsAndrographolide Research and Applications